SMT201500295B - Procedimento per la riduzione della pressione intraoculare negli umani - Google Patents

Procedimento per la riduzione della pressione intraoculare negli umani

Info

Publication number: SMT201500295B
Authority: SM; San Marino
Prior art keywords: humans; procedure; intraocular pressure; reducing intraocular; reducing
Prior art date: 2009-05-01

Application number

SM201500295T

Other languages

English (en)

Inventor

Shikha Barman

Rudolf A Baumgartner

Original Assignee

Inotek Pharmaceuticals Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-01

Filing date

2015-11-30

Publication date

2016-01-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43030847&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201500295(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-11-30 Application filed by Inotek Pharmaceuticals Corp filed Critical Inotek Pharmaceuticals Corp

2016-01-08 Publication of SMT201500295B publication Critical patent/SMT201500295B/it

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Ophthalmology & Optometry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Prostheses (AREA)

SM201500295T 2009-05-01 2015-11-30 Procedimento per la riduzione della pressione intraoculare negli umani SMT201500295B (it)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17465509P	2009-05-01	2009-05-01
US21999009P	2009-06-24	2009-06-24
PCT/US2010/033112 WO2010127210A1 (en)	2009-05-01	2010-04-30	Method of reducing intraocular pressure in humans

Publications (1)

Publication Number	Publication Date
SMT201500295B true SMT201500295B (it)	2016-01-08

Family

ID=43030847

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM201500295T SMT201500295B (it)	2009-05-01	2015-11-30	Procedimento per la riduzione della pressione intraoculare negli umani

Country Status (25)

Country	Link
US (2)	US8470800B2 (it)
EP (1)	EP2424546B1 (it)
JP (1)	JP5778663B2 (it)
KR (1)	KR101757940B1 (it)
CN (1)	CN102413832B (it)
AU (1)	AU2010242943B2 (it)
BR (1)	BRPI1009971A2 (it)
CA (1)	CA2762064A1 (it)
CL (1)	CL2011002675A1 (it)
DK (1)	DK2424546T3 (it)
EA (1)	EA024042B1 (it)
ES (1)	ES2554684T3 (it)
HR (1)	HRP20151200T1 (it)
HU (1)	HUE028068T2 (it)
IL (1)	IL216081A (it)
MX (1)	MX2011011229A (it)
MY (1)	MY159244A (it)
NZ (1)	NZ596428A (it)
PL (1)	PL2424546T3 (it)
PT (1)	PT2424546E (it)
RS (1)	RS54378B1 (it)
SG (1)	SG175346A1 (it)
SI (1)	SI2424546T1 (it)
SM (1)	SMT201500295B (it)
WO (1)	WO2010127210A1 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102008062567A1 (de)	2008-12-16	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de) *	2009-01-29	2010-08-05	Bayer Schering Pharma Aktiengesellschaft	Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
JP2013508420A (ja) *	2009-10-26	2013-03-07	イノテックファーマシューティカルズコーポレイション	点眼製剤およびその製造方法
ME02608B (me) *	2010-01-11	2017-06-20	Inotek Pharmaceuticals Corp	Kombinacija, komplet i postupak snižavanja intraokularnog pritiska
LT2555775T (lt) *	2010-03-19	2017-04-25	Inotek Pharmaceuticals Corporation	Adenozino a1 agonistų ir karboanhidrazės inhibitorių derinio kompozicijos, skirtos akispūdžio mažinimui
CN102958526A (zh) *	2010-03-19	2013-03-06	伊诺泰克制药公司	用于降低眼内压的腺苷A1激动剂与非选择性β-肾上腺素能受体阻断剂的组合型组合物
CN102933593A (zh) *	2010-03-26	2013-02-13	伊诺泰克制药公司	使用n6-环戊基腺苷（cpa）、cpa衍生物或其前药降低人眼内压的方法
DE102010030688A1 (de)	2010-06-30	2012-01-05	Bayer Schering Pharma Aktiengesellschaft	Substituierte Dicyanopyridine und ihre Verwendung
US20120058983A1 (en)	2010-09-02	2012-03-08	Bayer Pharma Aktiengesellschaft	Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
US9278991B2 (en) *	2012-01-26	2016-03-08	Inotek Pharmaceuticals Corporation	Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
BR112015021870A2 (pt)	2013-03-15	2017-07-18	Inotek Pharmaceuticals Corp	formulações oftálmicas
US20160158267A1 (en) *	2014-12-03	2016-06-09	Inotek Pharmaceuticals Corporation	Methods of preventing, reducing or treating macular degeneration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005249430B2 (en)	2004-05-26	2011-06-23	Inotek Pharmaceuticals Corporation	Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
CN101010085B (zh) *	2004-05-26	2012-12-26	伊诺泰克制药公司	嘌呤衍生物作为腺苷a1受体激动剂及其用法
AU2006320578B2 (en) *	2005-11-30	2013-01-31	Inotek Pharmaceuticals Corporation	Purine derivatives and methods of use thereof
JP2013508420A (ja) *	2009-10-26	2013-03-07	イノテックファーマシューティカルズコーポレイション	点眼製剤およびその製造方法
ME02608B (me) *	2010-01-11	2017-06-20	Inotek Pharmaceuticals Corp	Kombinacija, komplet i postupak snižavanja intraokularnog pritiska
LT2555775T (lt) *	2010-03-19	2017-04-25	Inotek Pharmaceuticals Corporation	Adenozino a1 agonistų ir karboanhidrazės inhibitorių derinio kompozicijos, skirtos akispūdžio mažinimui
CN102958526A (zh) *	2010-03-19	2013-03-06	伊诺泰克制药公司	用于降低眼内压的腺苷A1激动剂与非选择性β-肾上腺素能受体阻断剂的组合型组合物

2010
- 2010-04-30 HU HUE10770402A patent/HUE028068T2/en unknown
- 2010-04-30 AU AU2010242943A patent/AU2010242943B2/en not_active Ceased
- 2010-04-30 SI SI201031070T patent/SI2424546T1/sl unknown
- 2010-04-30 PT PT107704025T patent/PT2424546E/pt unknown
- 2010-04-30 CA CA2762064A patent/CA2762064A1/en not_active Abandoned
- 2010-04-30 NZ NZ596428A patent/NZ596428A/en not_active IP Right Cessation
- 2010-04-30 ES ES10770402.5T patent/ES2554684T3/es active Active
- 2010-04-30 DK DK10770402.5T patent/DK2424546T3/en active
- 2010-04-30 EA EA201171339A patent/EA024042B1/ru not_active IP Right Cessation
- 2010-04-30 KR KR1020117025057A patent/KR101757940B1/ko not_active Expired - Fee Related
- 2010-04-30 JP JP2012508764A patent/JP5778663B2/ja not_active Expired - Fee Related
- 2010-04-30 HR HRP20151200TT patent/HRP20151200T1/hr unknown
- 2010-04-30 EP EP10770402.5A patent/EP2424546B1/en active Active
- 2010-04-30 PL PL10770402T patent/PL2424546T3/pl unknown
- 2010-04-30 RS RS20150782A patent/RS54378B1/sr unknown
- 2010-04-30 BR BRPI1009971A patent/BRPI1009971A2/pt not_active IP Right Cessation
- 2010-04-30 US US12/771,289 patent/US8470800B2/en not_active Expired - Fee Related
- 2010-04-30 SG SG2011078151A patent/SG175346A1/en unknown
- 2010-04-30 MY MYPI2011004858A patent/MY159244A/en unknown
- 2010-04-30 WO PCT/US2010/033112 patent/WO2010127210A1/en not_active Ceased
- 2010-04-30 CN CN201080018539.XA patent/CN102413832B/zh not_active Expired - Fee Related
- 2010-04-30 MX MX2011011229A patent/MX2011011229A/es unknown
2011
- 2011-10-27 CL CL2011002675A patent/CL2011002675A1/es unknown
- 2011-11-01 IL IL216081A patent/IL216081A/en not_active IP Right Cessation
2013
- 2013-04-03 US US13/855,919 patent/US20130217643A1/en not_active Abandoned
2015
- 2015-11-30 SM SM201500295T patent/SMT201500295B/it unknown

Also Published As

Publication number	Publication date
MX2011011229A (es)	2011-11-18
JP5778663B2 (ja)	2015-09-16
IL216081A0 (en)	2012-01-31
JP2012525437A (ja)	2012-10-22
AU2010242943B2 (en)	2016-09-29
CN102413832B (zh)	2015-11-25
EP2424546B1 (en)	2015-10-28
MY159244A (en)	2016-12-30
HRP20151200T1 (hr)	2016-01-15
KR101757940B1 (ko)	2017-07-13
US20130217643A1 (en)	2013-08-22
RS54378B1 (sr)	2016-04-28
PT2424546E (pt)	2015-12-23
HK1167599A1 (en)	2012-12-07
AU2010242943A1 (en)	2011-12-01
IL216081A (en)	2015-11-30
EP2424546A1 (en)	2012-03-07
EA024042B1 (ru)	2016-08-31
PL2424546T3 (pl)	2016-04-29
NZ596428A (en)	2014-03-28
EA201171339A1 (ru)	2012-05-30
CA2762064A1 (en)	2010-11-04
SG175346A1 (en)	2011-11-28
DK2424546T3 (en)	2015-12-14
BRPI1009971A2 (pt)	2016-03-15
CN102413832A (zh)	2012-04-11
CL2011002675A1 (es)	2012-06-01
EP2424546A4 (en)	2013-01-23
ES2554684T3 (es)	2015-12-22
WO2010127210A1 (en)	2010-11-04
US8470800B2 (en)	2013-06-25
HUE028068T2 (en)	2016-11-28
KR20120017026A (ko)	2012-02-27
SI2424546T1 (sl)	2016-02-29
US20100279970A1 (en)	2010-11-04

Publication	Publication Date	Title
SMT201500295B (it)	2016-01-08	Procedimento per la riduzione della pressione intraoculare negli umani
EP2496182A4 (en)	2016-05-04	FLAP GRAFT
EP2393547A4 (en)	2012-09-26	RETINAL PROSTHESIS
EP2513299A4 (en)	2013-12-11	ADIPEOUS FABRIC DECELLULARIZED
EP2475287A4 (en)	2014-04-16	Child chair
EP2476885A4 (en)	2013-10-09	INTERNAL PRESSURE REGULATOR
DK2437762T3 (da)	2017-11-20	Kunstige tårer og terapeutiske anvendelser
BRPI1015403A2 (pt)	2016-08-09	válvula
EP2424476A4 (en)	2012-11-21	RETINA GRAFT
DK2401441T3 (da)	2014-06-23	Udluftningsventil
DE112010004770A5 (de)	2012-10-11	Rückschlagventil
DE112010002724A5 (de)	2012-06-14	Membranventil
EP2460523A4 (en)	2014-02-26	TABLET
SMT201700017B (it)	2017-03-08	Combinazione, kit e metodo per ridurre la pressione intraoculare
EP2767261C0 (en)	2024-05-22	Inflatable Penile Implant
BRPI1009887A2 (pt)	2016-03-08	unidade de válvula
EP2416228A4 (en)	2016-07-27	DECOMPRESSION VALVE
IT1397669B1 (it)	2013-01-18	Dispositivo di valvola del gas
EP2297527A4 (en)	2015-04-08	PRESSURE VALVE
DK2425134T3 (da)	2019-07-15	Kompressorventilarrangement
DK2255112T3 (da)	2014-09-29	Minimumtrykventil
EP2481416A4 (en)	2013-10-30	EYE DROP
FR2946083B1 (fr)	2011-06-17	Turbine basse-pression
EP2297526A4 (en)	2015-04-15	PRESSURE VALVE
SE0900379L (sv)	2010-03-02	Benstöd